Clinical Trial Update: Ligufalimab and Cadonilimab in Advanced Liver Cancers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on Ligufalimab and Cadonilimab in advanced hepatocellular carcinoma and biliary tract cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Hepatocellular Carcinoma

Drugs mentioned

• Cadonilimab
• Ligufalimab

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Advanced Hepatocellular Carcinoma, Refractory Hepatocellular Carcinoma | Phase 2 | Status: RECRUITING